Reduction central nervous system ischemic injury monoclonal antibody intercellular adhesion molecule ischemic central nervous system CNS injury Adhesion leukocytes essential migration binding adhesion receptors leukocyte CD intercellular adhesion molecule ICAM endothelium Monoclonal antibodies ICAM leukocyte adhesion transendothelial migration efficacy anti-ICAM antibody treatment neurological function CNS ischemia animal models dose anti-ICAM minutes induction ischemia spinal cord temporary aortic occlusion brain intra-arterial microspheres study treatment anti-ICAM significant reduction neurological deficits reversible spinal cord ischemia model irreversible brain ischemia model protective effect active role leukocytes CNS reperfusion ischemic injury potential future therapy 